6 ( ). 1.. 1. 2. 3. 4. 5. ( ) 6. 7. 8.
. 1. 1) 1 (12 3 ) 2
2) 3) ( ) ( ) 4) 2 () 2 2 3 5) ( )
R-Book ATLAS () 8 12 7 18 14 16 10 21 14 23 16 18 16 18 12 25 4 14 21 1 4 2 3 4 4 1 2 7 5 1 2 5 7 9 1 1 5 5 7 ( ) RS 2 8 7 10 7 14 2 1 2 3 4 3 8 3 4 2 4 2 5 21 1 2 7 28 ( 18 ) ( SARS )( A A H5N1 ) ((H5N1) ( ) ( ) () ()
5 2 (H5N1) ( ) (3 ) 5 3 5 2
. 1. 1) IgG IgM 2) 95% () 14 16 (10 21 ) 1 2 1 2 1 () 11 24 14 27 3) () ( 5 7 ) 4) 2 () (1) 1 2 ( 5 7 ) ID
3ml ( ) (2) 3 (72 ) 6 (100mg/kg 1 ) () () (20mg/kg 4 5 ) (3) 7 22 9 22 11 21 () 1 2 7 18-3 -2-1 1 2 3 4 5 2 5 10 21 3 3 7 22 (( ) (3 ) (9 ) (7 5 )
2. 1) 2 3 IgM RT-PCR (RNA) IgG 2008 1 1 1 - Secondary vaccine failure( ) 14 21 3 4 5 6 8 2) 95% () 8 12 7 18 3 4 ( 2 ) 4 ( ) 1 () 7 16 10 19 3) () 7
4) 2 () (1) 3 4 4 ID 3ml ( ) (2) 72 6 () () (20mg/kg 4 7 5 ) (3) 6 13 7 7 13 () 3 4 4 6 9-3 -2-1 1 2 3 4 5 6 7 8 12 3 3 6 13 ( ) (3 ) (6 )
3. 1) () ( HI 2008 1 1 1 2) 25 40% 14 23 16 18 7 5 (12 ) 3 10% 14 18% ( 4 ) 20% 1 3 1 3) () 5 4) 2 () (1) ID
3ml ( ) (2) 5) 7 21 5 7 21 () 7 5 7 14 7 3 2 14 23 7 7 21 ( )
4. 1) 25% 10 15% ( ) IgM 2 IgG 4 2) 16 18 12 25 1 2 5 () 7 9 -( 20 30% ) ( 5% ) (3 10%)(1/5 000 )(1/400 )( 30% ) 30 40% (2 ) 5 7 EIA-IgM 3) () 9 4) 2 () (1)
7 ID 3ml ( ) (2) 72 2 (1/12 000) (1/100 ) ( ) 5) 11 21 ( ) 9 11 21 () 7 9 7 18 7 9 5 16 18 7 7 25 ( )
5. ( ) 1) B19 (slapped-cheek) () B19 (IgM IgG ) B19 DNA PCR( ) 2) 4 14 21 70% 30 40% 1 ( ) 3) 4) 2 () 1 (Aplastic crisis) Aplastic crisis α- 20 40% 5)
6. 1) A B 2) ( 38) 1 1 4 ( 2 ) ( ) 5 7 3 3) ( ) ( ) 10 2010 ( ) ( ) ( 48 ) 1 2 2 (48 )
R R R R R A A &B A &B A &B A &B 5 5 5 2007 3 10 4) (1) 1 (2) (3 ) (3) (12 3 )
2 (4) (5) (6) (7) ( ) WEB 2013/02/27
(:3064 :5888) 5) ( ) 3 5 2 (3 ) ( 3 ) 6) 2 () (1) 1 ( ) 1 ( )
R 75(1 1 7 ) R (1 1 7 10 ) R 75 R 37.5kg R 75 1 1 10 R 3%1 2mg/kg( 66.7mg/kg) 1 1 10 1 75 mg R 4 3 3 7) 2
7. 1) RT-PCR PCR EIA 70% ( ) 2) 1 2 ( ) (SRSV) 100 1 100 10 7 28 2 3)
0.02% 0.05% 10 ( N95 ) 0.1% ( 2 )0.1% 10 0.05%10 24 48 4) (1) () () 1 (2) () (2 ) () (3) () ()
() (4) () (5) () (6) () 5) 0.02% 0.05% 0.02% 0.05%
( N95 ) 0.1% 2 0.1% () 0.1% ( ) ( 2 )0.1% 10 0.02% 0.05% 0.02% 0.05%
6) 2 () 3 3 7) 1 4 8)
8. (epidemic keratoconjunctivitis EKC) 1) 2008 51 A F 6 52 56 56 52 G A G D 8 19 37 QOL 70% 2) 7 14 3 2 ( ) 7 () 10 2 () () 70 A24 12 24 3 5 3) (1) () 80% 80%
(2) () (3) () 80% EKC () ( )( ) 0.1% 80933 10 0.05% 5 10 3w/v%( ) 10 ()
4) 2 () 3 7 14 3 14 3 3 3 5) 2 10 2